Cold-Eeze Cold Remedy Lozenges

Cold-Eeze is a well-known brand of homeopathic cold remedy lozenges specifically formulated to reduce the duration and severity of common cold symptoms through use of zinc gluconate. The product was originally developed by the ProPhase Labs, formerly known as The Quigley Corporation, in the 1990s. The brand gained significant popularity in the American market as one of the first widely marketed zinc-based remedies.

Over the years, the brand has undergone changes in corporate ownership to expand its reach. In 2017, the brand was acquired by Mylan N.V., a global generic and specialty pharmaceuticals company. Subsequently, in 2020, Mylan merged with Pfizer's Upjohn division to form a new healthcare giant called Viatris. Cold-Eeze remains a staple in the US retail market, manufactured primarily within the United States to ensure quality standards for over-the-counter supplements.

Today, Cold-Eeze is part of the extensive Viatris consumer healthcare portfolio. This ownership provides the brand with global distribution capabilities and R&D support, maintaining its position as a leading choice for consumers seeking clinically studied zinc lozenges during the cold and flu season.